MediciNova Inc (MNOV)
1.31
-0.07
(-5.07%)
USD |
NASDAQ |
May 03, 16:00
1.32
+0.01
(+0.76%)
After-Hours: 20:00
MediciNova Cash from Operations (Quarterly): -0.4991M for Dec. 31, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | -0.4991M |
September 30, 2023 | -1.372M |
June 30, 2023 | -2.383M |
March 31, 2023 | -3.177M |
December 31, 2022 | -4.007M |
September 30, 2022 | -2.720M |
June 30, 2022 | -2.456M |
March 31, 2022 | -3.728M |
December 31, 2021 | -3.639M |
September 30, 2021 | -3.016M |
June 30, 2021 | 1.127M |
March 31, 2021 | -3.854M |
December 31, 2020 | -1.949M |
September 30, 2020 | -3.908M |
June 30, 2020 | -2.091M |
March 31, 2020 | -2.879M |
December 31, 2019 | -2.404M |
September 30, 2019 | -2.039M |
June 30, 2019 | -1.652M |
March 31, 2019 | -3.029M |
December 31, 2018 | -1.644M |
September 30, 2018 | -1.736M |
June 30, 2018 | -1.653M |
March 31, 2018 | -4.081M |
December 31, 2017 | -1.046M |
Date | Value |
---|---|
September 30, 2017 | -1.919M |
June 30, 2017 | -1.411M |
March 31, 2017 | -2.547M |
December 31, 2016 | -1.059M |
September 30, 2016 | -1.582M |
June 30, 2016 | -1.486M |
March 31, 2016 | -2.419M |
December 31, 2015 | -1.517M |
September 30, 2015 | -1.170M |
June 30, 2015 | -1.233M |
March 31, 2015 | -3.234M |
December 31, 2014 | -1.033M |
September 30, 2014 | -1.591M |
June 30, 2014 | -1.328M |
March 31, 2014 | 4.768M |
December 31, 2013 | -4.022M |
September 30, 2013 | -1.906M |
June 30, 2013 | -2.097M |
March 31, 2013 | -2.622M |
December 31, 2012 | -2.187M |
September 30, 2012 | -2.407M |
June 30, 2012 | -3.844M |
March 31, 2012 | -3.427M |
December 31, 2011 | -0.9443M |
September 30, 2011 | -2.98M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-4.007M
Minimum
Dec 2022
1.127M
Maximum
Jun 2021
-2.455M
Average
-2.456M
Median
Jun 2022
Cash from Operations (Quarterly) Benchmarks
NovaBay Pharmaceuticals Inc | -0.314M |
Palatin Technologies Inc | -10.48M |
iBio Inc | -4.706M |
Theriva Biologics Inc | -6.541M |
Oragenics Inc | -1.102M |
Cash from Operations (Quarterly) Related Metrics
Free Cash Flow | -7.452M |
Free Cash Flow Per Share (Quarterly) | -0.0102 |
Free Cash Flow Yield | -11.60% |